Suppr超能文献

使用瞬时弹性成像技术预测获得持续病毒学应答的慢性丙型肝炎患者的肝脏相关事件

Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.

作者信息

Lee Hye Won, Chon Young Eun, Kim Seung Up, Kim Beom Kyung, Park Jun Yong, Kim Do Young, Ahn Sang Hoon, Jung Kyu Sik, Park Young Nyun, Han Kwang-Hyub

机构信息

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Gut Liver. 2016 May 23;10(3):429-36. doi: 10.5009/gnl15021.

Abstract

BACKGROUND/AIMS: Few studies have investigated prognostic factors for the development of liver-related events (LREs) in patients with chronic hepatitis C (CHC) who achieve sustained virological response (SVR).

METHODS

We analyzed 190 patients with CHC who achieved SVR after treatment with pegylated interferon (peg-IFN) plus ribavirin. LREs were defined as any complications related to cirrhosis, hepatocellular carcinoma (HCC), or liver-related mortality.

RESULTS

The mean age was 54.1 years, and 84 of the patients (44.2%) were male. The mean liver stiffness (LS) value at SVR was 7.1±5.4 kPa. During the follow-up period (median, 43.0 months), LREs occurred in 10 patients (5.3%; HCC in eight patients, ascites in one patient, and liver-related mortality in one patient). By multivariate Cox regression analysis, age, α-fetoprotein level, and LS value were independent predictors for LRE development (all p<0.05). Patients with LS values ≥7.0 kPa had a greater risk (hazard ratio, 9.472; 95% confidence interval, 1.018 to 88.126; p=0.048) for LRE development compared to those with LS values <7.0 kPa.

CONCLUSIONS

The LS value at SVR is useful for predicting LRE development in CHC patients who achieve SVR after treatment with peg-IFN plus ribavirin. Thus, LRE surveillance strategies might be optimized according to the LS values at SVR, even with complete viral eradication.

摘要

背景/目的:很少有研究调查过获得持续病毒学应答(SVR)的慢性丙型肝炎(CHC)患者发生肝脏相关事件(LRE)的预后因素。

方法

我们分析了190例接受聚乙二醇干扰素(peg-IFN)联合利巴韦林治疗后获得SVR的CHC患者。LRE被定义为与肝硬化、肝细胞癌(HCC)或肝脏相关死亡相关的任何并发症。

结果

患者平均年龄为54.1岁,其中84例(44.2%)为男性。SVR时的平均肝脏硬度(LS)值为7.1±5.4 kPa。在随访期(中位数为43.0个月)内,10例患者(5.3%)发生了LRE(8例为HCC,1例为腹水,1例为肝脏相关死亡)。通过多因素Cox回归分析,年龄、甲胎蛋白水平和LS值是LRE发生的独立预测因素(均p<0.05)。与LS值<7.0 kPa的患者相比,LS值≥7.0 kPa的患者发生LRE的风险更高(风险比为9.472;95%置信区间为1.018至88.126;p=0.048)。

结论

SVR时的LS值有助于预测接受peg-IFN联合利巴韦林治疗后获得SVR的CHC患者发生LRE。因此,即使病毒已被完全清除,也可根据SVR时的LS值优化LRE监测策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/339c/4849697/256d87eb5689/gnl-10-429f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验